Ormat Technologies (ORA) director sells 1,753 shares at $112.54

Ormat Technologies (ORA) reported an insider transaction on a Form 4.

Rhea-AI Filing Summary

Ormat Technologies (ORA) reported an insider transaction on a Form 4. A director sold 1,753 shares of common stock on 11/07/2025, coded S for an open-market sale at a price of $112.54 per share. Following the transaction, the insider reported 0 shares beneficially owned with direct (D) ownership. A footnote states the shares were sold in the open market on November 7, 2025.

Insights

Insider transactions analyst

Routine insider sale: 1,753 ORA shares at $112.54; holdings now 0.

The filing records a director’s open-market sale of 1,753 Ormat Technologies shares on 11/07/2025 at $112.54 per share, transaction code S. The explanatory note confirms this was an open-market trade on that date.

Post-transaction, the insider reports 0 shares beneficially owned, with direct ownership form indicated. This is a standard Form 4 disclosure and does not, by itself, signal operational or financial changes for the company.

Insider Trade Summary

Net Seller: 1,753 shares

Net Sell 1 txn

Insider Barniv Ravit

Role Director

Sold 1,753 shs ($197K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,753	$112.54	$197K

Holdings After Transaction: Common Stock — 0 shares (Direct)

Footnotes (1)

1. F1. Represents shares of common stock sold in the open market on November 7, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did ORA disclose?

A director sold 1,753 shares of Ormat Technologies common stock on 11/07/2025 in an open-market transaction.

At what price were the ORA shares sold?

The shares were sold at $112.54 per share.

What is the insider’s reported ownership after the sale?

The insider reported 0 shares beneficially owned following the transaction.

How was the transaction classified on the form?

The transaction was coded S, indicating an open-market or private sale of non-derivative securities.

Was this an open-market trade?

Yes. The footnote states the shares were sold in the open market on November 7, 2025.

What was the ownership form reported?

Ownership was listed as Direct (D).

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/10/2025 - 08:24 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Barniv Ravit

(Last) (First) (Middle)

C/O ORMAT TECHNOLOGIES, INC.

6884 SIERRA CENTER PARKWAY

(Street)

RENO NV 89511

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ORMAT TECHNOLOGIES, INC. [ ORA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/07/2025		S(1)		1,753	D	$112.54	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock sold in the open market on November 7, 2025.

	/s/ Jessica Woelfel - as attorney-in-fact	11/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.